Agennix
20
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
40.0%
8 terminated/withdrawn out of 20 trials
50.0%
-36.5% vs industry average
20%
4 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (20)
Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Role: collaborator
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Role: collaborator
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer
Role: lead
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy
Role: lead
Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
Role: lead
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Role: lead
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Role: lead
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies
Role: lead
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
Role: lead
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Role: lead
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Role: lead
Study of Satraplatin (JM-216) in Combination With Docetaxel
Role: lead
Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies
Role: lead
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Role: lead
Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Role: lead
Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants
Role: lead
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Role: lead
Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
Role: lead
Satraplatin and Vinorelbine in Advanced Solid Tumors
Role: collaborator
Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma
Role: lead
All 20 trials loaded